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Material and methods: Data	 from	 the	Netherlands	Perinatal	Registry	 (1999‐2010)	
were	used.	The	study	population	comprised	all	white	European	women	with	a	sin‐
gleton	delivery	between	25+0	and	42+6	weeks	of	gestation.	Fetuses	with	structural	
or	 chromosomal	 abnormalities	were	 excluded.	Outcomes	were	 antepartum	death,	
intrapartum/neonatal	death	(from	onset	of	labor	until	28	days	after	birth),	perinatal	






for	 gestation],	 p10‐90	 [normal	weight],	 >p90	 [large	 for	 gestation])	 and	 gestational	
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ies	have	 suggested	a	male	predominance	 in	miscarriage,10	 antepar‐
tum	 death,11‐13	 perinatal	 death,	 fetal	 distress,	 respiratory	 distress	









based	on	calculated	male	 to	 female	 ratio	 for	 adverse	outcome,	ex‐















neonatal	 morbidity,	 whilst	 correcting	 for	 fetal	 growth	 and	 gesta‐
tional	age	at	delivery.













gleton	 baby	 between	 25+0	 and	 42+6	weeks	 of	 gestation	 in	 The	




groups	 not	 taken	 into	 account	 in	 the	 Dutch	 birthweight	 refer‐
ence	curves	and	 to	avoid	bias	 through	 the	presence	of	different	
risk	 profiles	 for	 adverse	 pregnancy	 outcomes	 among	 non‐white	
European	women.
Gestational	 age	 at	 delivery	was	 defined	 as	 extremely	 preterm	
(25+0‐27+6	weeks),	very	preterm	(28+0‐31+6	weeks),	moderate	to	late	
preterm	 (32+0‐36+6	weeks)	 and	 term	 (37+0‐42+6	weeks).	The	Dutch	











found	no	 increased	 risk	of	 antepartum,	 intrapartum/neonatal	or	perinatal	death	 in	
normal	weight	and	large‐for‐gestation	males	born	after	28+0 weeks.




Small‐for‐gestational‐age	 males	 have	 increased	 risks	 of	
antepartum	 death;	 all	males	 born	 after	 32+0	weeks	 have	
increased	 risks	 of	 neonatal	morbidity	 compared	with	 fe‐
males.	 We	 found	 no	 increased	 risk	 of	 any	 mortality	 in	
normal	 weight	 or	 large‐for‐gestational‐age	 males	 after	
28+0 weeks.
     |  3VOSKAMP et Al.















considered	 to	 have	 suffered	 intrapartum/neonatal	 death	 and	 not	
morbidity.	 The	 composite	 measure	 of	 adverse	 perinatal	 outcome	
consisted	of	the	composite	measure	of	neonatal	morbidity	and	peri‐
natal	death.
PERINED	 registered	demographic	 and	obstetric	 characteristics	
including	maternal	age,	parity,	hypertensive	complications	of	preg‐
nancy	 (chronic	 hypertension,	 pregnancy‐induced	 hypertension,	








Demographic	 and	obstetric	baseline	 characteristics	were	 com‐
pared	 between	males	 and	 females	 using	 Student's	 t	 test	 and	Chi‐
square	test	as	appropriate.	We	tested	for	interaction	between	fetal	
sex	and	gestational	age	at	delivery	and	between	fetal	sex	and	birth‐
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an	 unknown	 gender	 (n	 =	 70	 [0.004%]),	 our	 study	 population	 con‐
sisted	of	1	742	831	pregnancies.
Baseline	characteristics	of	 the	cohort	are	presented	 in	Table	1.	














statistically	 significant	 for	 antepartum	death	 (P	 <	 0.001),	 intrapar‐
tum/neonatal	death	(P	<	0.001)	and	neonatal	morbidity	(P	<	0.001).	
Interaction	between	 fetal	 sex	 and	birthweight	percentile	was	 also	
significant	for	all	outcome	measures	(all	P	<	0.001).	Therefore,	out‐
comes	 are	 presented	 stratified	 for	 four	 strata	 of	 gestational	 age	
at	 delivery	 (25+0‐27+6	 weeks,	 28+0‐31+6	 weeks,	 32+0‐36+6	 weeks,	
37+0‐42+6	weeks)	 and	 three	 strata	 of	 birthweight	 percentile	 (SGA,	
normal	weight	and	LGA).
3.1 | Antepartum death
Table	 2	 shows	 the	 relative	 risk	 for	 antepartum	 death	 separately	
for	 four	 strata	 of	 gestational	 age	 at	 delivery	 (25+0‐27+6	 weeks,	
28+0‐31+6	 weeks,	 32+0‐36+6	 weeks,	 36+6‐42+6	 weeks)	 and	 three	
strata	of	birthweight	percentile	(SGA,	normal	weight	and	LGA).





significant	 difference	 between	males	 and	 females.	 The	 analysis	
 
Male infants Female infants
P value(n = 895 272) (n = 847 559)
Maternal	characteristics
Maternal	age,	years	(mean),	(SD) 30.7	(4.6) 30.7	(4.7) 0.24
Nulliparous,	n	(%) 426	995	(47.7) 403	106	(47.6) 0.08
Low	socioeconomic	status,	n	(%) 172	737	(19.3) 163	006	(19.2) 0.30
Pregnancy	and	delivery	characteristics
Conception	IVF/ICSI,	n	(%) 24	856	(2.8) 23	375	(2.8) 0.46
Hypertensive	disordersa,	n	(%) 83	170	(9.3) 76	100	(9.0) <0.0001







109	448	(12.2) 84	552	(10.0)  
Elective	cesarean,	n	(%) 55	269	(6.2) 55	556	(6.6)  





Delivery	<32	wk	GA,	(%) 8110	(0.9) 6438	(0.8) <0.0001
Delivery	<37	wk	GA,	(%) 57	353	(6.4) 45	980	(5.4) <0.0001
Birthweight	(g),	mean	(SD) 3525	(597) 3401	(564) <0.0001
Birthweight	<p10	(SGA) 79	442	(8.9) 75	691	(8.9)  
Birthweight	p10‐p90	(normal	
weight)
719	424	(80.4) 677	826	(80.0)  
Birthweight	≥p90	(LGA) 96	406	(10.8) 94	042	(11.1)  
Abbreviation:	SD,	standard	deviation.
aPreexisting	hypertension,	pregnancy‐induced	hypertension,	preeclampsia.	
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for	 all	 infants	 (not	 stratified	 into	 SGA,	 normal	weight	 and	 LGA)	
shows	 that	 antepartum	 death	 occurs	more	 often	 in	males	 than	
in	females	born	between	32+0	and	36+6	weeks	 (RR	1.12,	95%	CI	
1.02‐1.22).
3.2 | Intrapartum and neonatal death
Table	 3	 shows	 the	 rates	 of	 intrapartum/neonatal	 death.	 In	 most	
groups,	 there	were	 no	 significant	 differences	 between	males	 and	


























3.5 | Composite adverse perinatal outcome
The	composite	adverse	neonatal	outcome	of	males	and	 females	 is	
shown	in	Table	6.
The	 risk	 of	 composite	 adverse	 neonatal	 outcome	 was	 signifi‐
cantly	 increased	 in	 males	 compared	 with	 females	 in	 most	 (7/12)	
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight	<p10	(SGA)
25‐27	wk	GA 397/79	442 0.50 371/75	691 0.49 1.02 (0.89‐1.17)
28‐31	wk	GA 303/78	863 0.38 206/75	223 0.27 1.40 (1.17‐1.67)
32‐36	wk	GA 370/78	017 0.47 264/74	710 0.35 1.34 (1.15‐1.57)
37‐42	wk	GA 503/73	106 0.69 420/70	774 0.59 1.16 (1.02‐1.32)
Birthweight	p10‐p90	(normal	weight)
25‐27	wk	GA 277/719	424 0.04 304/677	826 0.04 0.86 (0.73‐1.01)
28‐31	wk	GA 404/718	042 0.06 422/676	696 0.06 0.90 (0.79‐1.03)
32‐36	wk	GA 597/713	388 0.08 563/673	002 0.08 1.00 (.89‐1.12)
37‐42	wk	GA 937/671	723 0.14 978/640	051 0.15 0.91 (0.83‐1.00)
Birthweight	≥p90	(LGA)
25‐27	wk	GA 31/96	406 0.03 29/94	042 0.03 1.04 (0.63‐1.73)
28‐31	wk	GA 46/96	243 0.05 44/93	850 0.05 1.02 (0.67‐1.54)
32‐36	wk	GA 36/95	757 0.04 24/93	409 0.03 1.46 (0.87‐2.45)
37‐42	wk	GA 131/93 090 0.14 122/90	754 0.13 1.05 (0.82‐1.34)
All	birthweights
25‐27	wk	GA 705/895	272 0.08 704/847	559 0.08 0.95 (0.85‐1.05)
28‐31	wk	GA 753/893	148 0.08 672/845	769 0.08 1.06 (0.96‐1.18)
32‐36	wk	GA 1003/887	162 0.11 851/841	121 0.10 1.12 (1.02‐1.22)






TA B L E  2  Antepartum	death	rate	
in	males	and	females	by	birthweight	
percentiles	and	gestational	age	category








The	 individual	 components	 of	 the	 composite	 neonatal	morbid‐
ity	 (IRDS,	 sepsis,	 NEC,	 meconium	 aspiration,	 PPHN,	 periventric‐
ular	 leukomalacia,	Apgar	score	<7	at	5	minutes	and	ICH)	were	also	




36+6	weeks	 the	 risk	of	sepsis	was	only	 increased	 in	normal	weight	
males	(Table	S2).	PPHN	was	only	increased	in	normal	weight	males	




with	 females	 regardless	 of	 gestational	 age	 at	 delivery	 and	 in	 LGA	









sessed	 differences	 in	 pregnancy	 outcomes	 between	 males	 and	
females	 after	 adjustments	 for	 differences	 in	 fetal	 growth.	 SGA	
males	 have	 an	 increased	 risk	 of	 antepartum	death	 and	 all	males	
born	after	32+0	weeks	of	gestation	have	an	increased	risk	of	neo‐




lated	 to	 the	 fact	 that	we	performed	 a	 database	 study	 and	 conse‐
quently	had	to	rely	on	information	that	was	recorded	in	the	registry.	




Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight	<p10	(SGA)
25‐27	wk	GA 61/182 34 41/97 42 .79 (0.58‐1.08)
28‐31	wk	GA 68/543 13 30/307 9.8 1.28 (0.85‐1.92)
32‐36	wk	GA 110/4541 2.4 103/3672 2.8 0.86 (0.66‐1.13)
37‐42	wk	GA 263/72	603 0.36 232/70	354 0.33 1.10 (0.92‐1.31)
Birthweight	p10‐p90	(normal	weight)
25‐27	wk	GA 298/1105 27 186/826 23 1.20 (1.02‐1.40)
28‐31	wk	GA 203/4250 4.8 173/3272 5.3 0.90 (0.74‐1.10)
32‐36	wk	GA 303/41	068 0.73 202/323	88 0.62 1.18 (0.99‐1.41)
37‐42	wk	GA 549/670	786 0.08 470/639	073 0.07 1.11 (0.98‐1.26)
Birthweight	≥p90	(LGA)
25‐27	wk	GA 21/132 16 36/163 22 0.72 (0.44‐1.17)
28‐31	wk	GA 33/440 7.5 31/397 7.8 0.96 (0.60‐1.54)
32‐36	wk	GA 24/2631 0.91 27/2631 1.0 0.89 (0.51‐1.54)
37‐42	wk	GA 64/92	959 0.07 53/90	632 0.06 1.18 (0.82‐1.69)
All	birthweights
25‐27	wk	GA 380/1419 27 263/1086 24 1.08 (0.94‐1.25)
28‐31	wk	GA 304/5233 5.8 234/3976 5.9 0.99 (0.84‐1.16)
32‐36	wk	GA 437/48	240 0.91 332/38	691 0.86 1.06 (0.92‐1.22)
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result	not	 reliably	 registered.	All	 these	 factors	are	associated	with	
adverse	pregnancy	outcome,	but	it	is	unlikely	that	there	is	a	fetal	sex‐















The	 PERINED	database	 does	 not	 contain	 quantitative	 data	 on	
the	method	of	pregnancy	dating.	According	to	the	ruling	guideline	
during	the	study	period,	pregnancy	dating	was	predominantly	per‐














of	antepartum	death	 is	 likely	 small	 at	 term,	because—according	 to	
the	Dutch	protocol—all	pregnant	women	in	the	term	period	undergo	




more	 accurate	 prediction	 of	 growth	 restriction	 and	 adverse	 out‐
come.24,25	We	were	not	 able	 to	 correct	 for	 this	 because	maternal	
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight	<p10	(SGA)
25‐27	wk	GA 458/579 79 412/468 88 0.77 (0.37‐0.73)
28‐31	wk	GA 371/846 44 236/513 46 0.96 (0.89‐1.05)
32‐36	wk	GA 480/4911 9.8 367/3936 9.3 1.02 (0.96‐1.09)
37‐42	wk	GA 766/73	106 1.0 652/70	774 0.92 1.06 (1.01‐1.12)
Birthweight	p10‐p90	(normal	weight)
25‐27	wk	GA 575/1382 42 490/1130 43 0.97 (.90‐1.04)
28‐31	wk	GA 607/4654 13 595/3694 16 0.89 (0.84‐0.95)
32‐36	wk	GA 900/41	665 2.2 765/32	951 2.3 0.97 (0.92‐1.01)
37‐42	wk	GA 1486/671	723 0.22 1448/640	051 0.23 0.99 (0.95‐1.03)
Birthweight	≥p90	(LGA)
25‐27	wk	GA 52/163 32 65/192 34 0.95 (0.73‐1.22)
28‐31	wk	GA 79/486 16 75/441 17 0.97 (0.81‐1.15)
32‐36	wk	GA 60/2667 2.2 51/2655 1.9 1.08 (0.89‐1.27)
37‐42	wk	GA 195/93	090 0.21 175/90	754 0.19 1.04 (0.94‐1.14)
All	birthweights
25‐27	wk	GA 1085/2124 51 967/1790 54 0.95 (0.89‐1.01)
28‐31	wk	GA 1057/5986 18 906/4648 19 0.95 (0.90‐0.99)
32‐36	wk	GA 1440/49	243 2.9 1183/39	542 3.0 0.99 (0.95‐1.03)





TA B L E  4  Perinatal	death	rate	in	males	
and	females	by	birthweight	percentiles	
and	gestational	age	category














compromised	 fetal	 condition	 rather	 than	 a	 confounder	of	 adverse	
















bidity	 that	 predominantly	 occur	 among	 extremely	 preterm	 infants	
and	causes	of	morbidity	that	occur	at	all	gestational	ages.	Separate	
tables	for	all	causes	of	morbidity	are	provided	as	Tables	S1‐S8.
The	 main	 strength	 of	 this	 study	 is	 the	 size	 (1	 742	 831	 preg‐
nancies)	 and	 composition	 of	 the	 cohort.	 Data	 are	 derived	 from	 a	
large,	well‐maintained	population‐based	national	perinatal	 registry	
(1999‐2010).	Cohorts	of	 all	 previous	 studies	were	 smaller	 (549	up	
to	469	152	pregnancies)11,25	and	often	included	anomalous	fetuses	









Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight	<p10	(SGA)
25‐27	wk	GA 94/121 78 48/56 86 0.91 (0.78‐1.05)
28‐31	wk	GA 324/475 68 190/277 69 0.99 (0.90‐1.10)
32‐36	wk	GA 535/4431 12 366/3569 10 1.18 (1.04‐1.33)
37‐42	wk	GA 1723/72	340 2.4 1320/70 122 1.9 1.27 (1.18‐1.36)
Birthweight	p10‐p90	(normal	weight)
25‐27	wk	GA 674/807 84 527/807 82 1.01 (0.97‐1.06)
28‐31	wk	GA 2602/4047 64 1861/3099 60 1.07 (1.03‐1.11)
32‐36	wk	GA 3754/40	765 9.2 2550/32	186 7.9 1.16 (1.11‐1.22)
37‐42	wk	GA 9292/670	237 1.4 6533/638	603 1.0 1.36 (1.31‐1.40)
Birthweight	≥p90	(LGA)
25‐27	wk	GA 87/111 78 105/127 83 0.95 (0.84‐1.08)
28‐31	wk	GA 248/407 60 197/366 54 1.13 (1.00‐1.28)
32‐36	wk	GA 274/2607 11 213/2604 8.2 1.28 (1.08‐1.52)
37‐42	wk	GA 1698/92	895 1.8 1233/90	579 1.4 1.34 (1.25‐1.44)
All	birthweights
25‐27	wk	GA 855/1039 82 680/823 83 0.99 (0.95‐1.04)
28‐31	wk	GA 3174/4929 64 2248/3742 60 1.07 (1.04‐1.11)
32‐36	wk	GA 4563/47	803 9.5 3129/38	359 8.2 1.17 (1.12‐1.22)

















the	outcomes	most	closely	 represent	 the	 influence	of	 fetal	sex	on	


































neous	 idea	 that	 all	male	 infants	 suffer	more	antepartum,	 intrapar‐
tum/neonatal	 and	 perinatal	 death	 than	 female	 infants.	 The	 main	
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight	<p10	(SGA)
25‐27	wk	GA 552/579 95 460/468 98 0.97 (0.95‐0.99)
28‐31	wk	GA 695/846 82 426/513 83 0.99 (0.94‐1.04)
32‐36	wk	GA 1015/4911 21 733/3936 19 1.11 (1.02‐1.21)
37‐42	wk	GA 2489/73	106 3.4 1972/70	774 2.8 1.22 (1.15‐1.30)
Birthweight	p10‐p90	(normal	weight)
25‐27	wk	GA 1249/1382 90 1017/1130 90 1.00 (0.98‐1.03)
28‐31	wk	GA 3209/4654 69 2456/3694 66 1.04 (1.01‐1.07)
32‐36	wk	GA 4654/41	665 11 3315/32	951 10 1.11 (1.06‐1.16)
37‐42	wk	GA 10	778/671	723 1.6 7981/640	051 1.2 1.29 (1.25‐1.32)
Birthweight	≥p90	(LGA)
25‐27	wk	GA 139/163 85 170/192 89 0.96 (0.89‐1.05)
28‐31	wk	GA 327/486 67 272/441 62 1.09 (0.99‐1.21)
32‐36	wk	GA 334/2667 13 264/2655 10 1.26 (1.08‐1.47)
37‐42	wk	GA 1893/93	090 2.0 1408/90	754 1.6 1.31 (1.22‐1.40)
All	birthweights
25‐27	wk	GA 1940/2124 91 1647/1790 92 0.99 (0.97‐1.01)
28‐31	wk	GA 4231/5986 71 3154/4648 68 1.04 (1.02‐1.07)
32‐36	wk	GA 6003/49	243 12 4312/39	542 11 1.12 (1.08‐1.16)
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implication	of	this	study	is	awareness	of	differences	between	male	





















We	 thank	 all	 Dutch	 midwives,	 obstetricians,	 neonatologists	 and	
other	perinatal	healthcare	providers	for	 the	registration	of	perina‐
tal	 information	 and	 the	 Foundation	 of	 the	 Netherlands	 Perinatal	
Registry	(www.perin	atreg.nl)	for	permission	(13.73)	to	use	the	reg‐
istry	data.




Myrthe J. C. S. Peelen  https://orcid.org/0000‐0002‐1281‐0911 
Brenda M. Kazemier  https://orcid.org/0000‐0002‐9735‐3747 




	 2.	 Davis	 RO,	 Cutter	 GR,	 Goldenberg	 RL,	 Hoffman	 HJ,	 Cliver	 SP,	





	 4.	 Harlow	 BL,	 Frigoletto	 FD,	 Cramer	 DW,	 et	 al.	 Determinants	 of	
preterm	 delivery	 in	 low‐risk	 pregnancies.	 The	 RADIUS	 Study	
Group.	J Clin Epidemiol.	1996;49:441‐448.
	 5.	 Ingemarsson	 I.	 Gender	 aspects	 of	 preterm	 birth.	 BJOG. 
2003;110(Suppl	20):34‐38.
	 6.	 McGregor	 JA,	 Leff	 M,	 Orleans	M,	 Baron	 A.	 Fetal	 gender	 differ‐
ences	in	preterm	birth:	findings	in	a	North	American	cohort.	Am J 
Perinatol.	1992;9:43‐48.
	 7.	 Melamed	N,	Yogev	Y,	Glezerman	M.	Fetal	 gender	 and	pregnancy	
outcome.	J Matern Fetal Neonatal Med.	2010;23:338‐344.
	 8.	 Zeitlin	 J,	 Saurel‐Cubizolles	 MJ,	 De	 Mouzon	 J,	 et	 al.	 Fetal	 sex	
and	 preterm	 birth:	 are	 males	 at	 greater	 risk?	 Hum Reprod. 
2002;17:2762‐2768.
	 9.	 Zeitlin	 J,	 Ancel	 PY,	 Larroque	 B,	 Kaminski	 M.	 Fetal	 sex	 and	 indi‐




	11.	 Jakobovits	 A,	 Jakobovits	 AA,	 Viski	 A.	 Sex	 ratio	 of	 the	 stillborn	
fetuses	 and	 neonates	 dying	 in	 the	 first	 week.	 Early Hum Dev. 
1987;15:131‐135.





Bruin	KM.	Male	predominance	 in	fetal	distress	during	 labor.	Am J 
Obstet Gynecol.	2002;187:1605‐1607.







differences	 in	 the	 Netherlands;	 care	 is	 the	 question.	BMC Public 
Health. 2009;9:102.
	18.	 Visser	GH,	Eilers	PH,	Elferink‐Stinkens	PM,	Merkus	HM,	Wit	 JM.	
New	Dutch	 reference	 curves	 for	 birthweight	 by	 gestational	 age.	
Early Hum Dev.	2009;85:737‐744.
	19.	 World	Health	Organization.	WHO Recommendations for Prevention 
and Treatment of Pre‐Eclampsia and Eclampsia.	Geneva:	WHO	Press;	
2011.
	20.	 Planbureau	SeC.	Van	hoog	naar	 laag;	 van	 laag	naar	hoog.	De	 so‐
ciaal‐ruimtelijke	 ontwikkeling	 van	 wijken	 tussen	 1971	 en	 1995.	
[From	high	to	low;	from	low	to	high.	The	socio‐spatial	development	
of	 neighborhoods	 between	 1971	 and	 1995.]	 (In	 Dutch).	 Rijswijk:	
Sociaal	en	Cultureel	Planbureau;	1998.










	25.	 Hutcheon	 JA,	McNamara	 H,	 Platt	 RW,	 Benjamin	 A,	 Kramer	MS.	
Placental	 weight	 for	 gestational	 age	 and	 adverse	 perinatal	 out‐
comes. Obstet Gynecol.	2012;119:1251‐1258.




     |  11VOSKAMP et Al.
	28.	 Eogan	MA,	Geary	MP,	O'Connell	MP,	Keane	DP.	Effect	of	fetal	sex	
on	labour	and	delivery:	retrospective	review.	BMJ.	2003;326:137.
	29.	 Quinones	 JN,	 Stamilio	 DM,	 Coassolo	 KM,	 Macones	 GA,	 Odibo	
AO.	 Is	 fetal	 gender	 associated	 with	 adverse	 perinatal	 outcome	










and	mortality	for	very	low	birthweight	infants.	Am J Obstet Gynecol. 
2007;196(147):e1‐e8.
	33.	 Kaandorp	JJ,	Benders	MJ,	Schuit	E,	et	al.	Maternal	allopurinol	admin‐
istration	during	 suspected	 fetal	 hypoxia:	 a	 novel	 neuroprotective	
intervention?	 A	 multicentre	 randomised	 placebo	 controlled	 trial.	
Arch Dis Child Fetal Neonatal Ed.	2015;100:F216‐F223.
SUPPORTING INFORMATION
Additional	 supporting	 information	 may	 be	 found	 online	 in	 the	
Supporting	Information	section	at	the	end	of	the	article.	
How to cite this article:	Voskamp	BJ,	Peelen	MJCS,	Ravelli	
ACJ,	et	al.	Association	between	fetal	sex,	birthweight	
percentile	and	adverse	pregnancy	outcome.	Acta Obstet 
Gynecol Scand.	2019;00:1‐11.	https	://doi.org/10.1111/
aogs.13709 
